Search
for
Sort by
Research 541–570 of 1000+
- Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- 53607 Common Contact Allergens Implicated in Frontal Fibrosing Alopecia Found in Over-the-Counter Hair Growth Serums and Solutions
- METROPOLITAN DERMATOLOGICAL SOCIETY OF NEW YORK
- Scalp roller therapy in resistant alopecia areata
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Treatment of Frontal Fibrosing Alopecia
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Adipose Tissue‐Derived Exosomes in the Treatment of Lichen Planopilaris: A Case Report
- Hair presentation test
- Alopecia Universalis with Frequently Relapsing Nephrotic Syndrome of Infantile Onset: A Rare Presentation
- Diphencyprone Induced Vitiligo: A Case Report
- Pulse corticosteroid therapy with oral dexamethasone for the treatment of adult alopecia totalis and universalis
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Battling a receding tide: Treatment for androgenic alopecia
- Unraveling a Rare Case: Diarrhea, Alopecia, and Polyposis
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Myeloproliferative disorder associated with alopecia universalis
- First drug for severe alopecia recommended by NICE could benefit 14,000 patients
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
- Alopecia areata after mogamulizumab treatment
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events